Related references
Note: Only part of the references are listed.How Might ZNF804A Variants Influence Risk for Schizophrenia and Bipolar Disorder? A Literature Review, Synthesis, and Bioinformatic Analysis
Jonathan L. Hess et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2014)
Brain-derived neurotrophic factor enhances cholinergic contraction of longitudinal muscle of rabbit intestine via activation of phospholipase C
M. Al-Qudah et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Polymorphisms in Serotonergic Pathways Influence the Outcome of Antidepressant Therapy in Psychiatric Inpatients
Julia Staeker et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2014)
Bdnf Deletion or TrkB Impairment in Amygdala Inhibits Both Appetitive and Aversive Learning
Scott A. Heldt et al.
JOURNAL OF NEUROSCIENCE (2014)
Characterisation of Genetic Variation in ST8SIA2 and Its Interaction Region in NCAM1 in Patients with Bipolar Disorder
Alex D. Shaw et al.
PLOS ONE (2014)
Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders
M. T. Ray et al.
TRANSLATIONAL PSYCHIATRY (2014)
Pharmacogenetics of antidepressant drugs: An update after almost 20 years of research
Chiara Fabbri et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2013)
Sustained in vivo blockade of α1-adrenergic receptors prevented some of stress-triggered effects on steroidogenic machinery in Leydig cells
Natasa J. Stojkov et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Stress susceptibility-specific phenotype associated with different hippocampal transcriptomic responses to chronic tricyclic antidepressant treatment in mice
Pawel Lisowski et al.
BMC NEUROSCIENCE (2013)
Association of Eveningness With Problem Behavior in Children: A Mediating Role of Impaired Sleep
Kristiaan B. van der Heijden et al.
CHRONOBIOLOGY INTERNATIONAL (2013)
The pharmacogenetics of antipsychotic-induced adverse events
Daniel J. Mueller et al.
CURRENT OPINION IN PSYCHIATRY (2013)
The interplay between rapid and slow corticosteroid actions in brain
Marian Joels et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Determinants of adherence to treatment in bipolar disorder: A comprehensive review
Emilie Leclerc et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
The Association Study of Polymorphisms in DAT, DRD2, and COMT Genes and Acute Extrapyramidal Adverse Effects in Male Schizophrenic Patients Treated With Haloperidol
Maja Zivkovic et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples
Alessandro Serretti et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
Harvey A. Whiteford et al.
LANCET (2013)
Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients
Raffaella Calati et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Intermediate Phenotype Analysis of Patients, Unaffected Siblings, and Healthy Controls Identifies VMAT2 as a Candidate Gene for Psychotic Disorder and Neurocognition
Claudia J. P. Simons et al.
SCHIZOPHRENIA BULLETIN (2013)
Genetic and neurocognitive foundations of emotion abnormalities in bipolar disorder
Tamsyn E. Van Rheenen et al.
COGNITIVE NEUROPSYCHIATRY (2013)
Genetic and clinical factors predict lithium's effects on PER2 gene expression rhythms in cells from bipolar disorder patients
M. J. McCarthy et al.
TRANSLATIONAL PSYCHIATRY (2013)
Molecular Mechanism Regulating 24-Hour Rhythm of Dopamine D3 Receptor Expression in Mouse Ventral Striatums
Eriko Ikeda et al.
MOLECULAR PHARMACOLOGY (2013)
Depression across mood disorders: review and analysis in a clinical sample
Daniel Souery et al.
COMPREHENSIVE PSYCHIATRY (2012)
Genomics and Pharmacogenomics of Brain Disorders
Ramon Cacabelos et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Less Cognitive and Neurological Deficits in Schizophrenia Patients Carrying Risk Variant in ZNF804A
Maarten J. A. Van den Bossche et al.
NEUROPSYCHOBIOLOGY (2012)
ZNF804a Regulates Expression of the Schizophrenia-Associated Genes PRSS16, COMT, PDE4B, and DRD2
Matthew J. Girgenti et al.
PLOS ONE (2012)
The Genetics of Antipsychotic Induced Tremors: A Genome-Wide Pathway Analysis on the STEP-BD SCP Sample
Antonio Drago et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2011)
The transcription factor SP4 is reduced in postmortem cerebellum of bipolar disorder subjects: control by depolarization and lithium
Raquel Pinacho et al.
BIPOLAR DISORDERS (2011)
ZNF804A may be associated with executive control of attention
Z. Balog et al.
GENES BRAIN AND BEHAVIOR (2011)
Phenomenology of psychotic mood disorders: Lifetime and major depressive episode features
Daniel Souery et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
The Leydig Cell MEK/ERK Pathway Is Critical for Maintaining a Functional Population of Adult Leydig Cells and for Fertility
Soichi Yamashita et al.
MOLECULAR ENDOCRINOLOGY (2011)
Cognitive state and connectivity effects of the genome-wide significant psychosis variant in ZNF804A
Christine Esslinger et al.
NEUROIMAGE (2011)
Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia
Joseph L. McClay et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia
Peixiong Yuan et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Activation of MAP Kinase in Lumbar Spinothalamic Cells Is Required for Ejaculation
Michael D. Staudt et al.
JOURNAL OF SEXUAL MEDICINE (2010)
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
M. Kato et al.
MOLECULAR PSYCHIATRY (2010)
Data quality control in genetic case-control association studies
Carl A. Anderson et al.
NATURE PROTOCOLS (2010)
Phosphorylation Changes of CaMKII, ERK1/2, PKB/Akt Kinases and CREB Activation During Early Long-Term Potentiation at Schaffer Collateral-CA1 Mouse Hippocampal Synapses
Mauro Racaniello et al.
NEUROCHEMICAL RESEARCH (2010)
Systematic Analysis of Circadian Genes in a Population-Based Sample Reveals Association of TIMELESS with Depression and Sleep Disturbance
Siddheshwar J. Utge et al.
PLOS ONE (2010)
The catechol-O-methyl-transferase gene in tardive dyskinesia
Clement C. Zai et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2010)
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
Jean-Martin Beaulieu et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2009)
Effects of 4-week Treatment with Lithium and Olanzapine on Levels of Brain-derived Neurotrophic Factor, B-Cell CLL/Lymphoma 2 and Phosphorylated Cyclic Adenosine Monophosphate Response Element-binding Protein in the Sub-regions of the Hippocampus
Michael D. Hammonds et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2009)
Role of serotonin in gastrointestinal motility and irritable bowel syndrome
Arbab Sikander et al.
CLINICA CHIMICA ACTA (2009)
BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease
T. Foltynie et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
5-HT4 Receptor-Mediated Neuroprotection and Neurogenesis in the Enteric Nervous System of Adult Mice
Min-Tsai Liu et al.
JOURNAL OF NEUROSCIENCE (2009)
The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment Curacao extrapyramidal syndromes study IX
B. Wilffert et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
The nuclear receptor RORα exerts a bi-directional regulation of IL-6 in resting and reactive astrocytes
Nathalie Journiac et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
An investigation of the α1A-adrenergic receptor gene and antipsychotic-induced side-effects
Pilar A. Saiz et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Psychotropic medications for patients with bipolar disorder in the United States: Polytherapy and adherence
Ross Baldessarini et al.
PSYCHIATRIC SERVICES (2008)
Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders
Amalia Lafuente et al.
PSYCHIATRY RESEARCH (2008)
PLINK: A tool set for whole-genome association and population-based linkage analyses
Shaun Purcell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients
Arzu Gunes et al.
PSYCHOPHARMACOLOGY (2007)
Enhanced endocrine response to novel environment stress and lack of corticosterone circadian rhythm in Staggerer (Rora sg/sg) mutant mice
Florence Frederic et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Genetic susceptibility to tardive dyskinesia among schizophrenia subjects: IV. Role of dopaminergic pathway gene polymorphisms
Vibhuti Srivastava et al.
PHARMACOGENETICS AND GENOMICS (2006)
What happens with adverse events during 6 months of treatment with selective serotonin reuptake inhibitors?
K Demyttenaere et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Reduced expression of the Sp4 gene in mice causes deficits in sensorimotor gating and memory associated with hippocampal vacuolization
X Zhou et al.
MOLECULAR PSYCHIATRY (2005)
The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation
J de Leon et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)
GS Sachs et al.
BIOLOGICAL PSYCHIATRY (2003)
A clinical monitoring form for mood disorders
GS Sachs et al.
BIPOLAR DISORDERS (2002)
Regulation of the activity of Sp1-related transcription factors
P Bouwman et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
CA Grimes et al.
PROGRESS IN NEUROBIOLOGY (2001)
Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer
AR Black et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2001)
Complex phenotype of mice homozygous for a null mutation in the Sp4 transcription factor gene
H Göllner et al.
GENES TO CELLS (2001)
Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia
RH Segman et al.
MOLECULAR PSYCHIATRY (2001)
Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia
VS Basile et al.
MOLECULAR PSYCHIATRY (2001)